Clinical Trials
- Diabetes
PREDICT Study : Phenotyping RElatives of persons with Diabetes with CGM and Tests of beta cell function and health (PREDICT): an integrated longitudinal assessment of deep metabolic phenotyping and CGM metrics in youth at risk for T1D
- Diabetes
Type 2 Diabetes Ultrasound Study
- Ages21 years - 75 years
- GenderBoth
- Diabetes
Testing Ultrasound as a new Treatment for Diabetes
- Diabetes
Hydroxychloroquine in Individuals At-risk for Type 1 Diabetes Mellitus (TN-22)
- Ages3 years and older
- GenderBoth
- Diabetes
FreeStyle Libre 2 Flash Glucose Monitoring System Intervention Phase Study for Pediatric Patients
- Ages4 years - 17 years
- GenderBoth